KpATCC43816 Protein target profile

phosphoenolpyruvate-protein phosphotransferase

Accession: VK055_4287

Gene: AIK82832.1 ptsP 3D evidence: AlphaFold DB model + ColabFold model Metabolism 3 reactions UniProt A0A0H3H2B7
Length 748
Pocket druggability (P2Rank · AlphaFold DB model) 0.848
Metabolic reactions 3
Chokepoint Yes
Direct ligand evidence 0 55 total records
Functional annotation 1 EC 9 GO
Target summary

Strong target candidate with converging metabolic, structural and chemical evidence.

Automated synthesis of the evidence currently loaded. Review the underlying records before prioritizing this protein.

Terms and data sources used on this page

PDB: experimentally determined structures from the Protein Data Bank. These are the strongest structural evidence, but may cover only part of the protein.

AlphaFold DB model: a precomputed predicted structure downloaded from AlphaFold Database/UniProt, not an experiment performed here.

ColabFold model: a predicted structure generated for this workspace; interpret it with coverage and confidence.

pLDDT: confidence score for predicted structures. High values support local geometry; low values mean the region should not drive pocket interpretation.

FPocket / P2Rank: software tools that predict possible ligand-binding pockets on a 3D structure. They are useful screening signals, not experimental validation.

Druggability: a pocket-based estimate of whether a small molecule could bind productively. It does not mean a drug already exists.

PDB ligand: a compound observed in an experimental structure. Direct same-protein records are stronger than homolog-transferred records.

ChEMBL: a public database of measured compound bioactivity. Direct entries are stronger than entries transferred from similar proteins.

ZINC: a purchasable-compound database. Here it marks proposed candidates from chemical similarity, not measured binders.

LigQ / LigQ_2: an internal Target pipeline step that gathers PDB, ChEMBL, and ZINC ligand evidence for each protein.

Off-target: sequence similarity to proteins we prefer not to hit, such as human proteins or beneficial gut microbiome proteins.

DEG: Database of Essential Genes. A match suggests the protein resembles genes known to be essential in other organisms.

Roary / CoreCruncher: pan-genome tools used to decide whether a gene is core across analyzed strains or accessory/strain-specific.

EC / GO: functional annotations: EC describes enzyme reactions; GO describes biological process, molecular function, or cellular component.

KEGG pathway: a curated metabolic route label used here to group reactions imported from the metabolic model.

Chokepoint: a metabolic reaction that is the only producer or consumer of a metabolite in the imported model.

Prioritization evidence

Selectivity, essentiality, structural confidence, conservation, and predicted binding-site evidence.

Off-target risk

Human off-target
No hit
Gut microbiome similarity
2.3% of screened genomes Lower prevalence suggests narrower overlap with the screened gut microbiome.

Essentiality

Essential (DEG)
N
DEG identity (%)
35.852 Higher values support similarity to known essential genes.

Structure confidence

ColabFold pLDDT
86.54 0-100 confidence; >70 supports local structural interpretation.

Binding-site evidence

AlphaFold DB / UniProt model

P2Rank's binding-site probability is the primary druggability signal shown across the app; FPocket's druggability score is shown alongside it for comparison. Both estimate small-molecule pocket quality after applying the curated structure priority — neither is experimental binding evidence. The 3D viewer may show a different loaded structure, so visible pockets can differ.

Druggability (P2Rank) 0.848
Structure A0A0H3H2B7
Pocket Pocket 1
Druggability (FPocket) 0.428
Structure A0A0H3H2B7
Pocket Pocket 28
ColabFold model
P2Rank 0.894 · Pocket 1
FPocket 0.851 · Pocket 8
Core conservation Conserved core gene
Roary core
CoreCruncher core
Gut microbiome 108 / 4744 genomes with a hit
Prevalence 2.3%

Metabolic context

Reactions catalyzed, pathway membership, and centrality in the genome-scale metabolic network.

Explore metabolic network

Attractive metabolic target: catalyzes a producing & consuming chokepoint reaction, no isoenzyme backup detected, more central than 90.2% of genes in this genome, no human homolog detected.

Relative network centrality 90.2% more central than 90.2% of genes in this genome
Chokepoint Chokepoint gene
Pathways

No specific KEGG pathway assigned - this reaction either has no KEGG mapping, or only matches a generic overview map with no route-level information.

Catalyzed reactions

3 reactions mapped to this gene in the metabolic model. Open the full network to see each one, with substrates/products and the reaction-reaction map.

Imported from KpATCC43816.sbml · 2026-07-09

Sequence

Primary amino-acid sequence viewer.

MLTRLREIVEKVASAPRLNEALDILVTDVCQAMETEVCSVYLADNDRRCYYLMATRGLKKPRGRTVALAFDEGLVGLVGRLAEPINLADAQKHPSFKYIPAVKEDRFRAFLGVPIIQRRQLLGVLVVQQRELRQFDESEESFLVTLATQMAAILSQSQLNALFGQYRQTRIRALPASSGVAIAEGWMDVSLPLMEQVYEASTLDTASERERLTGALEEAANEFRRYSKRYAAGAQKETAAIFDLYSHLLSDARLRRELFAEVDKGAVAEWAVKKIIEKFAEQFAALSDGYLKERAGDLRTLGQRLLFHLDDSIQGPNTWPARIILVADELSATTLAEVPQDRLAGVVVRDGAANSHAAIMVRALGIPTVMGADIQPSLLHGHTLIVDGYRGELLVDPEPVLLQEYQRLISEENELSRLAEDDLQRASELKSGERVKVMLNAGLSPEHEEKLGSFVDGIGLYRTEIPFMLQSGFPSEEEQVAQYQGMLQMFNSKPVTLRTLDIGADKQLPYMPISEENPCLGWRGIRITLDQPEIFLIQVRAMLRANAATGNLSILLPMVTSLEEVDEARRLIDRASREVEEMIGYAIPRPRLGVMLEVPSMVFMLPQLASRIDFISVGTNDLTQYLLAVDRNNTRVASMYDSLHPAVLRALAMIAHDAERFGIDLRLCGEMAGDPMCVTILIGLGYRHLSMNGRSVARVKYLLRRIDIEEAQELSRRSLDAQMTAEVRHQVAAFMERRGLGGLIRGGR

Functional annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 9 GO

Subcellular localization

Localization
Cytoplasmic

Enzyme Commission (EC)

1

Gene Ontology (GO)

9
  • GO:0016772 Catalysis of the transfer of a phosphorus-containing group from one compound (donor) to another (acceptor).
  • GO:0003824 Catalysis of a biochemical reaction at physiological temperatures. In biologically catalyzed reactions, the reactants are known as substrates, and the catalysts are naturally occurring macromolecular substances known as enzymes. Enzymes possess specific binding sites for substrates, and are usually composed wholly or largely of protein, but RNA that has catalytic activity (ribozyme) is often also regarded as enzymatic.
  • GO:0005515 Binding to a protein.
  • GO:0009401 The uptake and phosphorylation of specific carbohydrates from the extracellular environment; uptake and phosphorylation are coupled, making the PTS a link between the uptake and metabolism of sugars; phosphoenolpyruvate is the original phosphate donor; phosphoenolpyruvate passes the phosphate via a signal transduction pathway, to enzyme 1 (E1), which in turn passes it on to the histidine protein, HPr; the next step in the system involves sugar-specific membrane-bound complex, enzyme 2 (EII), which transports the sugar into the cell; it includes the sugar permease, which catalyzes the transport reactions; EII is usually divided into three different domains, EIIA, EIIB, and EIIC.
  • GO:0016310 The process of introducing a phosphate group into a molecule, usually with the formation of a phosphoric ester, a phosphoric anhydride or a phosphoric amide.
  • GO:0005737 The contents of a cell excluding the plasma membrane and nucleus, but including other subcellular structures.
  • GO:0016301 Catalysis of the transfer of a phosphate group, usually from ATP, to a substrate molecule.
  • GO:0046872 Binding to a metal ion.
  • GO:0008965 Catalysis of the reaction: phosphoenolpyruvate + protein L-histidine = pyruvate + protein N(pi)-phospho-L-histidine.

Sequence domains and features

Domain and signature matches imported from InterPro and related databases.

42 records
Show feature table
Start End DB Term Name
175 403 Gene3D G3DSA:3.50.30.10 Phosphohistidine domain
307 403 FunFam G3DSA:3.50.30.10:FF:000003 Phosphoenolpyruvate-protein phosphotransferase ptsP
351 362 ProSitePatterns PS00370 PEP-utilizing enzymes phosphorylation site signature.
351 362 InterPro IPR018274 PEP-utilising enzyme, active site
666 678 PRINTS PR01736 Phosphoenolpyruvate-protein phosphotransferase signature
613 628 PRINTS PR01736 Phosphoenolpyruvate-protein phosphotransferase signature
459 478 PRINTS PR01736 Phosphoenolpyruvate-protein phosphotransferase signature
630 645 PRINTS PR01736 Phosphoenolpyruvate-protein phosphotransferase signature
1 163 Gene3D G3DSA:3.30.450.40 -
1 163 InterPro IPR029016 GAF-like domain superfamily
209 229 Coils Coil Coil
1 162 FunFam G3DSA:3.30.450.40:FF:000012 Phosphoenolpyruvate-protein phosphotransferase PtsP
190 313 Gene3D G3DSA:1.10.274.10 -
190 313 InterPro IPR036618 PtsI, HPr-binding domain superfamily
82 738 PANTHER PTHR46244 PHOSPHOENOLPYRUVATE-PROTEIN PHOSPHOTRANSFERASE
558 578 Coils Coil Coil
425 714 SUPERFAMILY SSF51621 Phosphoenolpyruvate/pyruvate domain
425 714 InterPro IPR015813 Pyruvate/Phosphoenolpyruvate kinase-like domain superfamily
293 412 SUPERFAMILY SSF52009 Phosphohistidine domain
293 412 InterPro IPR036637 Phosphohistidine domain superfamily
404 736 Gene3D G3DSA:3.20.20.60 -
404 736 InterPro IPR040442 Pyruvate kinase-like domain superfamily
198 309 SUPERFAMILY SSF47831 Enzyme I of the PEP:sugar phosphotransferase system HPr-binding (sub)domain
198 309 InterPro IPR036618 PtsI, HPr-binding domain superfamily
18 152 Pfam PF01590 GAF domain
18 152 InterPro IPR003018 GAF domain
174 294 Pfam PF05524 PEP-utilising enzyme, N-terminal
174 294 InterPro IPR008731 Phosphotransferase system, enzyme I N-terminal
321 391 Pfam PF00391 PEP-utilising enzyme, mobile domain
321 391 InterPro IPR008279 PEP-utilising enzyme, mobile domain
190 313 FunFam G3DSA:1.10.274.10:FF:000002 Phosphoenolpyruvate-protein phosphotransferase PtsP
2 159 SUPERFAMILY SSF55781 GAF domain-like
425 707 Pfam PF02896 PEP-utilising enzyme, PEP-binding domain
425 707 InterPro IPR000121 PEP-utilising enzyme, C-terminal
17 164 SMART SM00065 gaf_1
17 164 InterPro IPR003018 GAF domain
404 736 FunFam G3DSA:3.20.20.60:FF:000012 Phosphoenolpyruvate-protein phosphotransferase PtsP
175 729 NCBIfam TIGR01417 phosphoenolpyruvate--protein phosphotransferase
175 729 InterPro IPR006318 Phosphotransferase system, enzyme I-like
402 422 Coils Coil Coil
613 631 ProSitePatterns PS00742 PEP-utilizing enzymes signature 2.
613 631 InterPro IPR023151 PEP-utilising enzyme, conserved site

3D structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; AlphaFold DB and ColabFold models typically cover the full protein but remain computational predictions.

Download VMD script Full viewer

Loading 3D structure...

Drag to rotate — click the view, then scroll to zoom.

Pocket score High Medium Low
How colors and pocket overlays are used
Uniform protein color marks the displayed model as a single molecular object.
Experimental PDB structures may be colored by chain to distinguish subunits or copies present in the file.
Pocket colors and alpha spheres are evidence overlays for predicted binding cavities; they are not alternative protein chains.
'Alpha spheres' is FPocket's own cavity-shape geometry, imported when available and aligned with the loaded structure.
'Pocket atoms'/'Predicted site atoms' show the pocket's residue atoms instead: P2Rank reports residues rather than alpha spheres, and FPocket falls back to this when alpha-sphere geometry is unavailable or doesn't align.
'No pocket geometry' means neither alpha spheres nor residue-position data could be found for that pocket; the layer just highlights the same residues as 'Nearby residues'.
Pocket details Inspect a specific pocket, or open the full viewer

Binding pockets · P2Rank

Druggability (P2Rank): high ≥ 0.5 · medium 0.2–0.49 · low < 0.2

Pocket 1 P2Rank #1
0.848
Show in viewer
Surrounding area
Pocket 2 P2Rank #2
0.435
Show in viewer
Surrounding area
Pocket 3 P2Rank #3
0.298
Show in viewer
Surrounding area
Pocket 4 P2Rank #4
0.154
Show in viewer
Surrounding area
Pocket 5 P2Rank #5
0.112
Show in viewer
Surrounding area

Binding pockets · FPocket

Druggability (FPocket): high ≥ 0.7 · medium 0.4–0.69 · low < 0.4

Pocket 1 FPocket #28
0.428
Show in viewer
Surrounding area
All structural evidence 0 experimental · 2 predicted

Structural evidence

0 + 2

Experimental PDB entries plus predicted AlphaFold DB or ColabFold models. Click Switch to display a different loaded structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold DB AF_A0A0H3H2B7
AlphaFold DB full sequence Viewing
ColabFold VK055_4287
ColabFold full sequence Loaded

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

55 records
Chemistry signal

Structural ligand evidence is available for this target.

Direct evidence 0 same-protein records
Transferred evidence 5 records from similar proteins
Structural ligands 5 0 loaded crystals
Measured bioactivity 0 direct and transferred ChEMBL records
Proposed compounds 50 similarity-based ZINC candidates
Best available ligand signal
6NQ PDB via homolog 569.1 Da · LogP -0.65 · TPSA 261.7 Open detail RCSB PDB
OXL PDB via homolog Detail RCSB PDB
P4G PDB via homolog Detail RCSB PDB
PEP PDB via homolog Detail RCSB PDB
PO3 PDB via homolog Detail RCSB PDB

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
6NQ RCSB PDB P22221 569.1 Da LogP -0.65 TPSA 261.7 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
OXL RCSB PDB P08839 88.0 Da LogP -3.51 TPSA 80.3 ✓ Ro5 ✓ Clean C(=O)(C(=O)[O-])[O-]
P4G RCSB PDB Q6FEW8 162.2 Da LogP 1.08 TPSA 27.7 ✓ Ro5 ✓ Clean CCOCCOCCOCC
PEP RCSB PDB P22221 168.0 Da LogP -0.31 TPSA 104.1 ✓ Ro5 ✓ Clean C=C(C(=O)O)OP(=O)(O)O
PO3 RCSB PDB P08839 79.0 Da LogP -1.64 TPSA 63.2 ✓ Ro5 ✓ Clean [O-][P-](=O)[O-]

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.

Cross-references

External database identifiers for this protein, its structures, ligands, and metabolic reactions.